Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
01/14/2009 | EP2012786A2 Pyridone sulfonamides and pyridone sulfamides as mek inhibitors |
01/14/2009 | EP1809600A4 Cyclic b-amino acid derivatives as factor xa inhibitors |
01/14/2009 | EP1663974B1 2-pyridone derivatives as netrophil elastase inhibitors and their use |
01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
01/14/2009 | CN101343248A Fine purification method for key intermediate of Donepezil Hydrochloride |
01/14/2009 | CN100450483C Stabilized pharmaceutical compositions contg. calcium channel blockers |
01/13/2009 | US7476727 Conjugates of mycophenolic acid |
01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
01/13/2009 | US7476682 N-substituted piperidine derivatives as serotonin receptor agents |
01/13/2009 | US7476681 anticarcinogenic agent; prostate cancer, benign prostatic hyperplasia, prostatic intraepithelial neoplasia, hirsutism, acne, androgenic alopecia, or polycystic ovary syndrome, prostate, lung, pancreatic, colon, renal cancer, myeloid leukemia |
01/13/2009 | US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
01/13/2009 | US7476672 Acetylenic compounds useful in treating inflammatory disorders |
01/13/2009 | CA2346506C Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
01/13/2009 | CA2271276C Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
01/08/2009 | WO2009006580A1 Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers |
01/08/2009 | WO2009005647A2 Compounds and process to prepare chiral intermediates for synthesis of paroxetine |
01/08/2009 | WO2009005077A1 Novel 4-{3-[4-(3-{4-[amino(butoxycarbonylimino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy]-n'-(butoxycarbonyl)benzamidine crystals |
01/08/2009 | WO2009004650A1 Novel substituted piperidones as hsp inducers |
01/08/2009 | WO2009003719A2 Indane-amine derivatives, their preparation and use as medicaments |
01/08/2009 | WO2008141462A9 Novel case of renin inhibitors |
01/08/2009 | WO2008134474A3 Compositions and methods including cell death inducers and procaspase activation |
01/08/2009 | WO2008119457A3 Lactam-substituted dicarboxylic acids and use thereof |
01/08/2009 | WO2008074450A3 Non-peptidic renin inhibitors nitroderivatives |
01/08/2009 | US20090012302 Method of isolating a nucleic acid using a material containing an amino group and a carboxyl group and positively charged at a first ph and a solid material for nucleic acid isolation used for the method |
01/08/2009 | US20090012301 Fexofenadine crystal form and processes for its preparation thereof |
01/08/2009 | US20090012300 Process for the Preparation of an (Hetero) Arylamine |
01/08/2009 | US20090012126 Certain chemical entities, compositions, and methods |
01/08/2009 | US20090012125 Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them |
01/08/2009 | US20090012121 Polymorphs of fexofenadine hydrochloride |
01/08/2009 | US20090012120 Synthesis of N-heterocycles, beta-amino acids, and allyl amines via aza-payne mediated reaction of ylides and hydroxy aziridines |
01/08/2009 | US20090012082 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
01/08/2009 | US20090012055 Piperidine derivatives such as 4-{4-[3-(2-Methoxybenzyloxy)propoxy]phenyl}-3-[3-methoxy-5-(3-methoxypropoxy)benzyloxy]piperidine, suitable as renin inhibitors, used for the treatment of hypertension, heart failure, glaucoma, cardiac infarction, kidney failure or restenosis; improved pharmacokinetics |
01/08/2009 | CA2695031A1 Novel substituted piperidones as hsp inducers |
01/08/2009 | CA2692513A1 Indane-amine derivatives, their preparation and use as medicaments |
01/08/2009 | CA2691954A1 Novel 4-{3-[4-(3-{4-[amino(butoxycarbonylimino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy}-n'-(butoxycarbonyl) benzamidine crystals |
01/07/2009 | EP2011786A1 Indane-amine derivatives, their preparation and use as medicaments |
01/07/2009 | EP2010491A1 Ropivacaine hydrochloride anhydrate and the preparation thereof |
01/07/2009 | EP2010490A2 Crystalline forms of a dimethylphenyl compound |
01/07/2009 | EP2010489A2 Dialkylphenyl compounds having 2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
01/07/2009 | EP2010488A2 Renin inhibitors |
01/07/2009 | EP2010479A1 11 beta-hydroxysteroid dehydrogenase type 1 active compounds |
01/07/2009 | EP2010165A2 Abnormal cannabidiols as agents for lowering intraocular pressure |
01/07/2009 | EP2009992A2 Il-8 receptor antagonists |
01/07/2009 | EP1928821B1 Carboxamide derivatives as muscarinic receptor antagonists |
01/07/2009 | EP1858867B1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
01/07/2009 | EP1807072B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
01/07/2009 | CN101341122A Novel process for production of highly pure polymorph (I) donepezil hydrochloride |
01/07/2009 | CN101337922A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
01/07/2009 | CN100448847C Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation |
01/07/2009 | CN100448846C Method for catalytic hydrogenation of acyl pyridine to preparing substituted pyridine compound hydrochlorate |
01/07/2009 | CN100448844C Inhibitors of histone deacetylase |
01/06/2009 | US7473795 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors |
01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
01/06/2009 | US7473698 Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof |
01/06/2009 | US7473697 2-Oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders |
01/06/2009 | US7473692 Sulfonamide derivatives as D3-receptor ligands |
01/06/2009 | CA2421008C Substituted heterocyclic compounds for treating multidrug resistance |
01/06/2009 | CA2414095C Novel compounds |
01/06/2009 | CA2295446C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
01/06/2009 | CA2288533C New 4-substituted piperidines |
01/01/2009 | US20090005571 Process for Preparing Imino Compounds |
01/01/2009 | US20090005569 Process for the preparation of 4-trifluoromethyl-2(1h)-pyridinone |
01/01/2009 | US20090005414 Polymorph of N,N-Diethyl-4-(3-Fluorophenyl-Piperidin-4-Ylidene-Methyl)-Benzamide Hydrochloride Salt |
01/01/2009 | US20090005363 Organic Compounds |
01/01/2009 | US20090005355 Piperidine Compound and Process for Preparing the Same |
01/01/2009 | US20090005353 used in treating and/or preventing cardiovascular disorders, inflammatory diseases, Alzheimer's disease, dyslipidemia and metabolic syndrome |
01/01/2009 | US20090005323 Cathepsin K Inhibitors and Obesity |
12/31/2008 | WO2009001127A1 Cyanocyclopropylcarboxamides as cathepsin inhibitors |
12/31/2008 | WO2009000878A1 Kallikrein 7 modulators |
12/31/2008 | EP2009000A1 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
12/31/2008 | EP2007725A2 Non-peptidic renin inhibitors nitroderivatives |
12/31/2008 | EP2007724A1 Piperidine derivatives for treatment of alzheimer's disease |
12/31/2008 | EP2007723A2 Organic compounds |
12/31/2008 | EP2007722A1 Adamantane derivatives for the treatment of the metabolic syndrome |
12/31/2008 | EP2007705A1 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
12/31/2008 | EP1339864B1 Process for the production of piperidine derivatives with microorganisms |
12/31/2008 | EP1276741B1 Phenyl substituted 4-hydroxy tetrahydropyridone and its use as pesticide and herbicide |
12/31/2008 | CN101333186A Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
12/31/2008 | CN101333185A Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
12/31/2008 | CN101333184A Processes for the preparation of (r)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4 piperidinemethanol |
12/31/2008 | CN101333174A N-bridged selective androgen receptor modulators and methods of use thereof |
12/31/2008 | CA2691849A1 Kallikrein 7 modulators |
12/30/2008 | US7470817 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
12/30/2008 | US7470812 Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the synthesis of (S)-Pregabalin |
12/30/2008 | US7470789 Anhydrous crystalline fexofenadine hydrochloride; H1 receptor antagonist; antihistaminic drug; reduction of ketonic form, salt formation |
12/30/2008 | US7470711 Piperidinyl substituted cyclohexane-1,4-diamines |
12/30/2008 | CA2349195C New manufacturing process |
12/30/2008 | CA2275192C Novel preparation method for derivatives of 4-phenyl-1,2,3,6-tetrahydropyridine and the intermediate products activated thereby |
12/30/2008 | CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
12/30/2008 | CA2226256C New thrombin inhibitors, their preparation and use |
12/25/2008 | US20080319235 Process for the preparation of ring compounds |
12/25/2008 | US20080319197 Crystalline Form of Remifentanil Hydrochloride |
12/25/2008 | US20080319196 Process for Synthesizing Remifentanil |
12/25/2008 | US20080319016 Novel Arylamidine Derivative, Salt Thereof, and Antifungal Containing These |
12/25/2008 | US20080318956 Inflammatory cytokine release inhibitor |
12/24/2008 | WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
12/24/2008 | WO2008106104A3 Environmentally sensitive fluorophores |
12/24/2008 | WO2008070692A8 Bicyclic compounds and use as antidiabetics |